US 4033825A
· Haddad et al.
· 1977
[cited by applicant]
US 4143764A
· Moss
· 1979
[cited by applicant]
US 4291786A
· Ito
· 1981
[cited by applicant]
US 4601730A
· McGowan et al.
· 1986
[cited by applicant]
US 5117870A
· Goodale et al.
· 1992
[cited by applicant]
US 5449617A
· Falkenberg
· 1995
[cited by examiner]
US 5506117A
· Andrews et al.
· 1996
[cited by applicant]
US 5686304A
· Codner et al.
· 1997
[cited by applicant]
US 5693537A
· Wilson et al.
· 1997
[cited by applicant]
US 5707869A
· Wolf et al.
· 1998
[cited by applicant]
US 5726450A
· Peterson et al.
· 1998
[cited by applicant]
US 5985153A
· Dolan et al.
· 1999
[cited by applicant]
US 6410309B1
· Barbera-Guillem et al.
· 2002
[cited by applicant]
US 6455310B1
· Barbera-Guillem
· 2002
[cited by applicant]
US 6479252B1
· Barbera-Guillem et al.
· 2002
[cited by applicant]
US 6821772B2
· Barbera-Guillem et al.
· 2004
[cited by applicant]
US 6900055B1
· Fuller et al.
· 2005
[cited by applicant]
US 7601545B2
· Barringer, Jr.
· 2009
[cited by applicant]
US 7745209B2
· Martin
· 2010
[cited by examiner]
US 7919307B2
· Klaus et al.
· 2011
[cited by applicant]
US 7964392B2
· Hatano et al.
· 2011
[cited by applicant]
US 8158427B2
· Wilson
· 2012
[cited by examiner]
US 8492140B2
· Smith et al.
· 2013
[cited by applicant]
US 8956860B2
· Vera et al.
· 2015
[cited by applicant]
US 9110114B2
· Nezuka et al.
· 2015
[cited by applicant]
US 9175253B2
· Hata
· 2015
[cited by applicant]
US 9206383B2
· Vunkak-Novakovic
· 2015
[cited by applicant]
US 9255243B2
· Wilson et al.
· 2016
[cited by applicant]
US 9315774B2
· Knaus et al.
· 2016
[cited by applicant]
US 9441192B2
· Wilson et al.
· 2016
[cited by applicant]
US 9732317B2
· Wilson et al.
· 2017
[cited by applicant]
US 20040214314A1
· Srienc et al.
· 2004
[cited by applicant]
US 20050051723A1
· Neagle et al.
· 2005
[cited by applicant]
US 20080000902A1
· Holbrook et al.
· 2008
[cited by applicant]
US 20080227190A1
· Antwiler
· 2008
[cited by applicant]
US 20090037031A1
· George et al.
· 2009
[cited by applicant]
US 20100291534A1
· Higuchi et al.
· 2010
[cited by applicant]
US 20130157353A1
· Dijkhuizen Borgart
· 2013
[cited by examiner]
US 20150072401A1
· Nozaki et al.
· 2015
[cited by applicant]
US 20150344833A1
· Kimura et al.
· 2015
[cited by applicant]
US 20160355777A1
· Fachin et al.
· 2016
[cited by applicant]
US 20170058242A1
· Martin et al.
· 2017
[cited by applicant]
US 20170253847A1
· Koseki
· 2017
[cited by applicant]
US 20180298321A1
· Koseki et al.
· 2018
[cited by applicant]
US 20210087510A1
· Griffin et al.
· 2021
[cited by applicant]
CN 1501835A
· 2004
[cited by applicant]
CN 101014712A
· 2007
[cited by applicant]
CN 102504991A
· 2012
[cited by applicant]
CN 104640973A
· 2015
[cited by applicant]
CN 105392877A
· 2016
[cited by applicant]
CN 106459915A
· 2017
[cited by applicant]
CN 106466495A
· 2017
[cited by applicant]
CN 106536055A
· 2017
[cited by applicant]
CN 106573241A
· 2017
[cited by applicant]
CN 107454862A
· 2017
[cited by applicant]
EP 0950432A1
· 1999
[cited by applicant]
EP 1944359A1
· 2008
[cited by applicant]
EP 2589652A1
· 2013
[cited by applicant]
EP 3081627A1
· 2016
[cited by applicant]
EP 3196289A1
· 2017
[cited by applicant]
GB 2268187A
· 1994
[cited by applicant]
JP S55177534U
· 1980
[cited by applicant]
JP S57100900A
· 1982
[cited by applicant]
JP 2002542004A
· 2002
[cited by applicant]
JP 2003504195A
· 2003
[cited by applicant]
JP 2006149232A
· 2006
[cited by applicant]
JP 2007535965A
· 2007
[cited by applicant]
JP 2009502183A
· 2009
[cited by applicant]
JP 2009514796A
· 2009
[cited by applicant]
JP 2013223820A
· 2013
[cited by applicant]
JP 2013539356A
· 2013
[cited by applicant]
JP 2014033889A
· 2014
[cited by applicant]
JP 2015188391A
· 2015
[cited by applicant]
JP 2015221002A
· 2015
[cited by applicant]
JP 2015223169A
· 2015
[cited by applicant]
JP 2016221001A
· 2015
[cited by applicant]
JP 2016153124A
· 2016
[cited by applicant]
JP 2016170623A
· 2016
[cited by applicant]
JP 2017513499A
· 2017
[cited by applicant]
JP 2021512633A
· 2021
[cited by applicant]
KR 1020080072006A
· 2008
[cited by applicant]
KR 1020160145162A
· 2016
[cited by applicant]
WO 199600780A1
· 1996
[cited by applicant]
WO 9724144A1
· 1997
[cited by applicant]
WO 0950432A1
· 1999
[cited by applicant]
WO 2000050175A1
· 2000
[cited by applicant]
WO 02070120A1
· 2002
[cited by applicant]
WO 02102965A2
· 2002
[cited by applicant]
WO 03087292A2
· 2003
[cited by applicant]
WO 2005009126A1
· 2005
[cited by applicant]
WO 2005108589A1
· 2005
[cited by applicant]
WO 2007052718A1
· 2007
[cited by applicant]
WO 2008109200A1
· 2008
[cited by applicant]
WO 2009072003A2
· 2009
[cited by applicant]
WO 2009112952A2
· 2009
[cited by applicant]
WO 2010040748A1
· 2010
[cited by applicant]
WO 2010062599A1
· 2010
[cited by applicant]
WO 2010080032A2
· 2010
[cited by applicant]
WO 2012079000A1
· 2012
[cited by applicant]
WO 2013114845A1
· 2013
[cited by applicant]
WO 2013184800A2
· 2013
[cited by applicant]
WO 2014051503A1
· 2014
[cited by applicant]
WO 2015001321A1
· 2015
[cited by applicant]
WO 2015042450A1
· 2015
[cited by applicant]
WO 2015039115A1
· 2015
[cited by applicant]
WO 2015056302A1
· 2015
[cited by applicant]
WO 2015120096A2
· 2015
[cited by applicant]
WO 2015162211A1
· 2015
[cited by applicant]
WO 2016007216A1
· 2016
[cited by applicant]
WO 2016012459A2
· 2016
[cited by applicant]
WO 2016100227A1
· 2016
[cited by applicant]
WO 2016107788A1
· 2016
[cited by applicant]
WO 2016113369A1
· 2016
[cited by applicant]
WO 2016118780A1
· 2016
[cited by applicant]
WO 2016161174A1
· 2016
[cited by applicant]
WO 2016168687A1
· 2016
[cited by applicant]
WO 2016185221A1
· 2016
[cited by applicant]
WO 2016189159A1
· 2016
[cited by applicant]
WO 2017032829A1
· 2017
[cited by applicant]
WO 2017035262A1
· 2017
[cited by applicant]
WO 2017038887A1
· 2017
[cited by applicant]
WO 201760534A1
· 2017
[cited by applicant]
WO 201785899A1
· 2017
[cited by applicant]
WO 2017109083A1
· 2017
[cited by applicant]
WO 2017109074A1
· 2017
[cited by applicant]
WO 2017144440A2
· 2017
[cited by applicant]
WO 2017190254A1
· 2017
[cited by applicant]
WO 2017221155A1
· 2017
[cited by applicant]
WO 2018005521A2
· 2018
[cited by applicant]
WO 2018111931A1
· 2018
[cited by applicant]
WO 2018122192A1
· 2018
[cited by applicant]
WO 2019046766A2
· 2019
[cited by applicant]
WO 2019155026A1
· 2019
[cited by applicant]
WO 2019155030A1
· 2019
[cited by applicant]
WO 2019155031A2
· 2019
[cited by applicant]
Office Action and Search Report Issued in Chinese Patent Application No. 202080010621.1, dated Sep. 5, 2022 with English Translation (21 pages).
[cited by applicant]
Office Action Issued in Japanese Patent Application No. 2020-529614, dated Sep. 12, 2022 with English Summary (12 pages).
[cited by applicant]
Japanese Office Action for JP Application No. 2020-542856, mailed Jan. 10, 2023 (8 pages, with English translation).
[cited by applicant]
Japanese Office Action for JP Application No. 2020-542889, mailed Jan. 10, 2023 (22 pages, with English translation).
[cited by applicant]
Japanese Office Action for JP Application No. 2020-542847, mailed Jan. 10, 2023 (10 pages, with English translation).
[cited by applicant]
Japanese Office Action for JP Application No. 2020-542846, mailed Dec. 23, 2022 (9 pages, with English translation).
[cited by applicant]
Japanese Office Action for JP Application No. 2020-542890, mailed Jan. 4, 2023 (9 pages, with English translation).
[cited by applicant]
Indian First Examination Report for IN Application No. 202017032170 mailed Jul. 8, 2022 (5 pages).
[cited by applicant]
Singapore Written Opinion for SG Application No. 11202004646T mailed Aug. 6, 2021 (6 pages).
[cited by applicant]
Singapore Written Opinion for SG Application No. 11202007140X mailed Aug. 2, 2021 (7 pages).
[cited by applicant]
Singapore Written Opinion for SG Application No. 11202007439T mailed Aug. 2, 2021 (6 pages).
[cited by applicant]
Chinese Office Action for CN Application No. 202080010621.1 mailed Sep. 5, 2022 (21 pages, with English translation).
[cited by applicant]
Japanese Office Action for JP Application No. 2020-529614 mailed Sep. 12, 2022 (12 pages, with English translation).
[cited by applicant]
Schwarz, Ray P., et al.; “Cell Culture For Three-Dimensional Modeling in Rotating-Wall Vessels: An Application of Simulated Microgravity”, Journal of tissue culture methods, vol. 14, Issue 02, pp. 51-57, Jun. 1992.
[cited by applicant]
Hung, Paul J., et al.; “A Novel High Aspect Ratio Microfluidic Design to Provide a Stable and Uniform Microenvironment for cell Growth in a High Throughput Mammalian Cell Culture Array”, Link of General Homepage, vol. 0…
[cited by applicant]
Shojaosadati, Seyed Abbas, et al.; “Recent Advances in High Cell Density Cultivation for Production of Recombinant Protein”, Iranian Journal of Biotechnology, vol. 06, Issue 02, pp. 63-84, 2008.
[cited by applicant]
International Search Report for PCT/EP Application No. 2019/053210, issued May 22, 2019 (13 pages).
[cited by applicant]
International Search Report for PCT/EP Application No. 2019/053209, issued May 13, 2019 (14 pages).
[cited by applicant]
International Search Report for PCT/EP Application No. 2019/053212, issued May 27, 2019 (9 pages).
[cited by applicant]
International Search Report for PCT/EP Application No. 2019/053208, issued May 21, 2019 (13 pages).
[cited by applicant]
International Search Report for PCT/EP Application No. 2019/053206, issued May 15, 2019 (12 pages).
[cited by applicant]
Rnational Search Report for PCT/EP Application No. 2019/053211, issued May 29, 2019 (10 pages).
[cited by applicant]
International Search Report for PCT/EP Application No. 2019/053205, issued Apr. 30, 2019 (12 pages).
[cited by applicant]
International Search Report for PCT/EP Application No. 2019/053207, issued May 3, 2019 (13 pages).
[cited by applicant]
U.S. Office Action issued Mar. 21, 2022 in corresponding U.S. Appl. No. 16/968,342; 32 pages.
[cited by applicant]
Japanese Office Action for JP Application No. 2020-542891, mailed Jan. 26, 2023 (8 pages, with English translation).
[cited by applicant]
United States Office Action for U.S. Appl. No. 16/968,342, mailed Apr. 6, 2023 (26 pages).
[cited by applicant]
Korean Office Action for KR Application No. 10-2020-7025562 mailed Sep. 19, 2023 (20 pages, with English translation).
[cited by applicant]
Korean Office Action for KR Application No. 10-2020-7025576 mailed Sep. 19, 2023 (19 pages, with English translation).
[cited by applicant]
Office Action issued in U.S. Appl. No. 16/968,304, dated Oct. 5, 2023 (12 pages).
[cited by applicant]
First Office Action issued in China application No. 201980024225.1, dated Sep. 1, 2023 (18 pages).
[cited by applicant]
Office Action issued in U.S. Appl. No. 16/968,333, dated Sep. 20, 2023 (8 pages).
[cited by applicant]
First Office Action issued in China application No. 201980024234.0, dated Aug. 29, 2023 (15 pages).
[cited by applicant]
First Office Action issued in China application No. 201980024224.7, dated Aug. 31, 2023 (22 pages).
[cited by applicant]
First Office Action issued in China application No. 201980024223.2, dated Aug. 16, 2023 (24 pages).
[cited by applicant]
First Office Action issued in China application No. 201980024235.5, dated Aug. 30, 2023 (15 pages).
[cited by applicant]
Office Action issued in U.S. Appl. No. 16/968,374, dated Jan. 17, 2024 (46 pages).
[cited by applicant]
Hollyman et al. “Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.” Journal of Immunotherapy, vol. 32(2): pp. 169-180. (Year: 2009).
[cited by applicant]
Office Action issued in U.S. Appl. No. 16/968,315, dated Jan. 17, 2024, 28 pages.
[cited by applicant]
Office Action issued in China Application No. 201880088322.2, dated Dec. 21, 2023, 7 pages.
[cited by applicant]
Examination Report issued in Australian Application No. 2019219295, dated Nov. 30, 2023, 3 pages.
[cited by applicant]
Examination Report issued in Australian Application No. 2019219292, dated Dec. 7, 2023, 3 pages.
[cited by applicant]
Examination Report issued in Indian Application No. 202017032170, dated Feb. 5, 2024, 2 pages.
[cited by applicant]
Examination Report issued in Australian Application No. 2019219241, dated Nov. 28, 2023, 3 pages.
[cited by applicant]
Office Action in Chinese Application No. 201980024013.3, dated May 1, 2024, 7 pages.
[cited by applicant]
Office Action in Chinese Application No. 201980024222.8, dated May 29, 2024, 12 pages.
[cited by applicant]
Office Action issued in United States U.S. Appl. No. 17/734,562, dated Feb. 26, 2024, 70 pages.
[cited by applicant]
Office Action issued in United States U.S. Appl. No. 17/734,562, dated May 2, 2022, 15 pages.
[cited by applicant]
Office Action issued in KR Application No. 10-2020-7018529, mailed Sep. 13, 2024, 12 pages.
[cited by applicant]
Perfusion culture of T lymphocytes in the WAVE Bioreactor tm System 2/10 (software version 2.61), GE Healthcare Life Sciences, Cell Expansion, Application note 28-9650-52 AC, 9 pages.
[cited by applicant]
Mock, et al. “Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy Using CliniMACS Prodigy”, Cytotherapy, 2016' 18: 1002-1011, 11 pages.
[cited by applicant]
Office Action issued in MX Application No. MX/a/2020/008317, mailed Aug. 22, 2024, 12 pages.
[cited by applicant]
Singh, “Disposable bioreactor for cell culture using wave-induced agitation”, Cytotechnology, 30 :: 149-158, 1999.
[cited by applicant]
Office Action issued in U.S. Appl. No. 16/968,304, mailed Dec. 19, 2024, 28 pages.
[cited by applicant]
Office Action issued in CA Application No. 3082861, mailed Mar. 11, 2025, 6 pages.
[cited by applicant]
Office Action issued in JP Application No. 2023-215870, mailed Feb. 18, 2025.
[cited by applicant]
Office Action issued in CA Application No. 3,090,047, mailed Jun. 20, 2025, 4 pages.
[cited by applicant]
Office Action issued in U.S. Appl. No. 18/400,052, mailed May 21, 2025, 70 pages.
[cited by applicant]
Office Action issued in AU Application No. 2019219291, mailed Sep. 11, 2024, 3 pages.
[cited by applicant]
Office Action issued in Japanese application No. 2023-215870, dated Aug. 25, 2025 (6 pages), English translation.
[cited by applicant]
Office Action issued in Canadian application No. 3,090,447, dated Aug. 15, 2025 (6 pages).
[cited by applicant]
Office Action issued in Canadian application No. 3,089,788, dated Aug. 15, 2025 (6 pages).
[cited by applicant]
https://catalog.takara-bio.co.jp/PDFS/retronection_201601.pdf, “For Increasing Efficiency in Gene Transfer Using Retrovirus/Lentivirus? RetroNectin”, [online], 2021, Acquisition Date: Aug. 25, 2025 (3 pages).
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/423,202, dated Aug. 4, 2025, 23 pages.
[cited by applicant]